Multifocal: a strategic bidirectional transformation language for XML schemas

Lenses are one of the most popular approaches to define bidirectional transformations between data models. However, writing a lens transformation typically implies describing the concrete steps that convert values in a source schema to values in a target schema. In contrast, many XML-based languages allow writing structure-shy programs that manipulate only specific parts of XML documents without having to specify the behavior for the remaining structure. In this paper, we propose a structure-shy bidirectional two-level transformation language for XML Schemas, that describes generic type-level transformations over schema representations coupled with value-level bidirectional lenses for document migration. When applying these two-level programs to particular schemas, we employ an existing algebraic rewrite system to optimize the automatically-generated lens transformations, and compile them into Haskell bidirectional executables. We discuss particular examples involving the generic evolution of recursive XML Schemas, and compare their performance gains over non-optimized definitions.Fundação para a Ciência e a Tecnologi

Generic point-free lenses

Lenses are one the most popular approaches to define bidirectional transformations between data models. A bidirectional transformation with view-update, denoted a lens, encompasses the definition of a forward transformation projecting concrete models into abstract views, together with a backward transformation instructing how to translate an abstract view to an update over concrete models. In this paper we show that most of the standard point-free combinators can be lifted to lenses with suitable backward semantics, allowing us to use the point-free style to define powerful bidirectional transformations by composition. We also demonstrate how to define generic lenses over arbitrary inductive data types by lifting standard recursion patterns, like folds or unfolds. To exemplify the power of this approach, we “lensify” some standard functions over naturals and lists, which are tricky to define directly “by-hand” using explicit recursion

Transforming data by calculation

Thispaperaddressesthefoundationsofdata-modeltransformation.A catalog of data mappings is presented which includes abstraction and representa- tion relations and associated constraints. These are justified in an algebraic style via the pointfree-transform, a technique whereby predicates are lifted to binary relation terms (of the algebra of programming) in a two-level style encompassing both data and operations. This approach to data calculation, which also includes transformation of recursive data models into “flat” database schemes, is offered as alternative to standard database design from abstract models. The calculus is also used to establish a link between the proposed transformational style and bidi- rectional lenses developed in the context of the classical view-update problem.Fundação para a Ciência e a Tecnologia (FCT

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Oscillateur MMIC fonctionnant à 45GHz à base de transistor TBH InP/GaAsSb/InP

National audienc

Fetal heart rate patterns in labors with intact and with ruptured membranes

Peer Reviewe

V-Band Amplifier MMICs Using Multi-Finger InP/GaAsSb DHBT Technology

We report on the development of a multi-finger InP/GaAsSb DHBT technology, optimized for the fabrication of RF MMICs. Geometry (number of fingers) and structure optimization has allowed to get FT~200 GHz and FMAX>300 GHz, to suit microwave applications. Special attention has been paid to critical thermal behavior. Key devices have been modeled using a modified Gummel-Poon model. Based on these models, and a passive devices library, RF amplifiers have been designed to operate at 60 GHz, fabricated using the developed process, using 2-finger devices, and measured. 1-stage amplifier delivers 5.5 dB, and 2-device 2-stage amplifier achieves up to 10 dB gain

A GaAsSb/InP HBT circuit technology

A InP/GaAsSb/InP double-heterojunction bipolar transistor (DHBT) structure has been defined, realized by MBE epitaxy, and optimized, thanks to simulation based on in-depth physical characterizations. A circuit-oriented technology has been developed, which has been validated by the design and fabrication of a full-rate (40 GHz clock) 40 Gbit/s D-FF

Three Complementary Approaches to Bidirectional Programming

Abstract. This paper surveys three distinct approaches to bidirectional programming. The first approach, syntactic bidirectionalization, takes a program describing the forward transformation as input and calculates a well-behaved reverse transformation. The second approach, semantic bidirectionalization, is similar, but takes the forward transformation itself as input rather than a program describing it. It requires the transformation to be a polymorphic function and uses parametricity and free theorems in the proof of well-behavedness. The third approach, based on bidirectional combinators, focuses on the use of types to ensure wellbehavedness and special constructs for dealing with alignment problems. In presenting these approaches, we pay particular attention to use of complements, which are structures that represent the information discarded by the transformation in the forward direction.